Article Information
History
- August 4, 2020.
Article Versions
- You are currently viewing Version 1 of this article (August 4, 2020 - 04:12).
- Version 2 (December 2, 2020 - 10:07).
- View Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Author Information
- Hanna M. Ollila1,2,3,#,
- Markku Partinen4,5,
- Jukka Koskela1,2,6,
- Riikka Savolainen7,
- Anna Rotkirch8 and
- Liisa T. Laine9,10,#
- 1Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland
- 2Broad Institute of MIT and Harvard, Cambridge, MA, USA
- 3Stanford University School of Medicine, Palo Alto, CA, USA
- 4Helsinki Sleep Clinic, Vitalmed Research Center
- 5Department of Clinical Neurosciences, Clinicum, University of Helsinki, Helsinki, Finland
- 6Helsinki University and Helsinki University Hospital, Clinic of Gastroenterology Helsinki, Finland
- 7Newcastle University Business School, Newcastle-upon-Tyne, United Kingdom
- 8Population Research Institute, Väestöliitto – The Family Federation of Finland
- 9University of Pennsylvania, The Wharton School, Philadelphia, PA, USA
- 10Department of Medical Ethics and Health Policy, The Perelman School of Medicine, Philadelphia, PA, USA
- ↵#Corresponding author: Hanna M. Ollila, FIMM-EMBL Group leader, Institute for Molecular Medicine Finland, University of Helsinki, Finland; hanna.m.ollila{at}helsinki.fi and Liisa T. Laine, Department of Medical Ethics and Health Policy, The Perelman School of Medicine, Philadelphia, PA, USA; lainel{at}wharton.upenn.edu